One-year change in the health status predicts the subsequent hospitalization and mortality in patients waitlisted for lung transplantation in Japan.
暂无分享,去创建一个
H. Date | T. Oga | S. Sugimoto | Y. Okada | A. Ohsumi | H. Kayawake | T. Chen-Yoshikawa | S. Tanaka | Y. Yutaka | D. Nakajima | M. Hamaji | Yusuke Wakatsuki | J. Tokuno | M. Akiba | M. Ikeda | Yoshito Yamada | Megumi Ishihara | Jumpei Kimura
[1] H. Date,et al. Patient-reported dyspnea and health predict waitlist mortality in patients waiting for lung transplantation in Japan , 2021, Respiratory Research.
[2] H. Date,et al. Analysis of Optimal Health-Related Quality of Life Measures in Patients Waitlisted for Lung Transplantation , 2020, Canadian respiratory journal.
[3] L. Lancaster,et al. Associations between Patient-reported Outcomes and Death or Lung transplant in IPF: Data from the IPF-PRO Registry. , 2020, Annals of the American Thoracic Society.
[4] N. Schoof,et al. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials , 2020, Respiratory Research.
[5] A. Prasse,et al. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry , 2019, Respiratory Research.
[6] N. Kolaitis,et al. Defining Success in Lung Transplantation: From Survival to Quality of Life , 2018, Seminars in Respiratory and Critical Care Medicine.
[7] H. Date. Current status and problems of lung transplantation in Japan. , 2016, Journal of thoracic disease.
[8] T. Egan,et al. Effect of the lung allocation score on lung transplantation in the United States. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] H. Date,et al. Lung allocation score and health-related quality of life in Japanese candidates for lung transplantation. , 2015, Interactive cardiovascular and thoracic surgery.
[10] L. Edwards,et al. One-year change in health status and subsequent outcomes in COPD , 2015, Thorax.
[11] S. Narumiya,et al. Clinical Relevance of Plasma Prostaglandin F2α Metabolite Concentrations in Patients with Idiopathic Pulmonary Fibrosis , 2013, PloS one.
[12] P. Blanc,et al. A Thematic Analysis of Quality of Life in Lung Transplant: The Existing Evidence and Implications for Future Directions , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] C. Tantucci,et al. Lung function decline in COPD , 2012, International journal of chronic obstructive pulmonary disease.
[14] F L Grover,et al. Development of the New Lung Allocation System in the United States , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] P. Jones. St. George's Respiratory Questionnaire: MCID , 2005, COPD.
[16] M. Tsukino,et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.
[17] P. Jones,et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.
[18] R. Snaith,et al. The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.